News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|July 22, 2024

Addressing Vaccine Fatigue

Author(s)Ryan Haumschild, PharmD, MS, MBA, Wanda Filer, MD, MBA, Marty J. Feltner, PharmD

Mary Bridgeman, PharmD, BCPS, BCGP, discusses how providers and healthcare workers can address vaccine fatigue in patients eligible for the RSV vaccine.

Episodes in this series

A panel of 5 experts on RSV

EP. 1 Overview of RSV Patient Populations

Marty J. Feltner, PharmD, an expert on RSV

EP. 2 Complications Associated with RSV Infections

A panel of 5 experts on RSV

EP. 3 The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV

A panel of 5 experts on RSV

EP. 4 RSV: Risk Factors and How It’s Spread

A panel of 5 experts on RSV

EP. 5 Diagnostic Practices for RSV

A panel of 5 experts on RSV

EP. 6 Increasing Awareness of RSV Vaccines in At-Risk Patients

A panel of 5 experts on RSV

EP. 7 Shared Decision-Making Practices in RSV

A panel of 5 experts on RSV

EP. 8 Financial and Clinical Benefits of RSV Immunization

A panel of 5 experts on RSV

EP. 9 The Potential Benefits of RSV Vaccine Approval for Adults Aged 50-59

A panel of 5 experts on RSV

EP. 10 Addressing Vaccine Fatigue

A panel of 5 experts on RSV

EP. 11 Identifying Patients Eligible for RSV Vaccine

A panel of 5 experts on RSV

EP. 12 Current and Potential Obstacles Related to Administering RSV Vaccines

A panel of 5 experts on RSV

EP. 13 Improving Insurance Coverage for RSV Vaccines

A panel of 5 experts on RSV

EP. 14 Improving RSV Vaccination Rates and Addressing Misinformation

A panel of 5 experts on lung cancer

EP. 15 Key Takeaways on RSV Vaccination

Video content above is prompted by the following question:

How can providers and healthcare workers address vaccine fatigue in eligible patients?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Child receiving vaccine | Image credit: Drazen - stock.adobe.com

Experts Warn That CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

ByBrooke McCormick

January 27th 2026

CDC headquarters | Image Credit: Katherine Welles - stock.adobe.com

Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns

ByBrooke McCormick

January 26th 2026

Doctor talking with older patient | Image credit: ryanking999 - stock.adobe.com

Meta-Analysis Supports RSV Vaccine Efficacy and Safety in Older Adults

ByKimberly Rath, PharmD

December 30th 2025

Findings suggest that early monitoring of chemokines could help facilitate treatment planning by more quickly identifying patients at risk of severe disease. | Image credit: Rochu_2008 - stock.adobe.com

Potential Biomarkers of RSV Bronchiolitis Severity Identified

ByJared Kaltwasser

December 26th 2025

Top 5 RSV Content of 2025

ByMaggie L. Shaw

December 21st 2025

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text